Alamar Biosciences Inc stock is traded at $26.48, with a volume of 712,583. It is down -7.67% in the last 24 hours and down -5.97% over the past month. Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Previous Close:
$28.68
Open:
$28.25
24h Volume:
712,583
Relative Volume:
1.20
Market Cap:
$1.84B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-14.05%
1M Performance:
-5.97%
6M Performance:
+31.35%
1Y Performance:
0.00%
1-Day Range:
$26.24$28.25
1-Week Range:
$26.24$32.00
52-Week Range:
$18.85$39.61
Alamar Biosciences Inc Stock (ALMR) Company Profile
Name
Alamar Biosciences IncSector
HealthcareIndustry
Medical DevicesPhone
510-626-9888Address
47071 BAYSIDE PARKWAY, FREMONT, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS